ISPC vs TFX · rev $9.3M vs P/E 2083, rev $3.05B
iSpecimen Inc (ISPC) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
ISPC currently screens at market cap $4.4M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the ISPC and TFX stock pages for the full models.
Not investment advice.